Table 2 The relationship between Enah expression and clinicopathological characteristics of GC
From: Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer
Variable | Total | Enah expression | p | |||
---|---|---|---|---|---|---|
Negative (−~+) | Positive (++) | Strong positive (+++) | ||||
90 | 14 | 23 | 53 | |||
Gender | Male | 70 | 10 | 21 | 39 | 0.192 |
Female | 20 | 4 | 2 | 14 | ||
Age (y) | ≥60 | 61 | 8 | 13 | 40 | 0.174 |
<60 | 29 | 6 | 10 | 13 | ||
AJCC stage | Stage 1 + 2 | 37 | 10 | 8 | 19 | 0.040 |
Stage 3 + 4 | 53 | 4 | 15 | 34 | ||
Depth of invasion | T1 + T2 | 11 | 6 | 1 | 4 | <0.001 |
T3 + T4 | 79 | 8 | 22 | 49 | ||
Nodal status | N0 | 23 | 4 | 8 | 11 | 0.419 |
N1 + N2 + N3 | 67 | 10 | 15 | 42 | ||
Distant metastasis | M0 | 86 | 14 | 21 | 51 | 0.430 |
M1 | 4 | 0 | 2 | 2 | ||
Pathological classification | I + II | 24 | 5 | 5 | 14 | 0.646 |
III + IV | 66 | 9 | 18 | 39 |